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Aim: To compare the performance of keratoconus, penetrating keratoplasty (PK), and control subjects on
clinical tests of contrast and glare vision, to determine whether differences in vision were independent of
visual acuity (VA), and thereby establish which vision tests are the most useful for outcome studies of PK for
keratoconus.
Methods: All PK subjects had keratoconus before grafting and no subjects had any other eye disease. The
keratoconus (n = 11, age 35.0 (SD 11.1) years), forme fruste keratoconus (n = 6, 33.0 (13.0)), PK (n = 21,
41.2 (7.9)), and control (n = 24, 33.7 (8.6)) groups were similar in age. Vision testing, conducted with
optimal refractive correction in place, included low contrast visual acuity (LCVA) and Pelli-Robson contrast
sensitivity (PRCS) both with and without glare, as well as VA.
Results: Normal subjects saw better than PK subjects who in turn saw better than keratoconus subjects on
all raw measures. However, when adjusted for VA, the normal group only saw significantly better than the
keratoconus group on LCVA (low contrast loss 0.05 (0.04) v 0.15 (0.12), F2,48 = 6.16; p,0.01, post hoc
Sheffé p,0.05), and the decrements to glare were no worse than for normals. The forme fruste
keratoconus group were indistinguishable from normals on all measures.
Conclusions: PK subjects have superior vision to keratoconus subjects, but not as good as normal subjects.
Including mild keratoconus subjects within a keratoconus group could confound these differences in vision.
While VA is an excellent test for comparing normal, keratoconus and PK groups, additional information
can be provided by LCVA and PRCS, but not by glare testing. Outcomes research into keratoconus
management should include a measure in the contrast domain.
K
eratoconus was first described by Nottingham in 1854,1
and has been comprehensively reviewed by several
authors since.2–6 Visual acuity (VA) has been the
mainstay of assessing the progression of the severity of
keratoconus and the effectiveness of treatment.7–9 Visual
acuity is also an important factor in determining the change
in treatment method from spectacles to rigid contact lenses
and on to penetrating keratoplasty (PK).3 However, the
inadequacy of high contrast VA as an indicator of visual
quality is widely appreciated.10
Several studies have investigated other measures of vision
in keratoconus. Most of these have looked at contrast
sensitivity (CS),11–22 and some have demonstrated that the
loss of contrast sensitivity in keratoconus cannot be predicted
from VA measurement.12 13 18 The value of low contrast visual
acuity (LCVA) testing in keratoconus is less clear. While
LCVA has shown to be reduced in keratoconus,9 14 19 23–25 the
independence of this reduction from VA has not been
established.
Penetrating keratoplasty has been demonstrated to be an
effective treatment for keratoconus, as measured by an
improvement in VA.7 8 However, contrast vision after PK for
keratoconus has not been so well studied. Contrast sensitivity
after PK is usually better than in keratoconus,15–17 19 22 26 27 but
not in all studies.27–29 Further research on this seems
warranted. Low contrast visual acuity in PK has had minimal
investigation with one study reporting some abnormal
values,19 and another showing no difference from keratoco-
nus eyes.28 Glare testing in keratoconus and PK subjects has
been the subject of several small studies that have shown
glare losses in keratoconus greater than in normals or PK
subjects.16 17 22 30 However, two studies have shown glare
losses greater after PK than in keratoconus.15 16 This confu-
sion is at odds with the clinical impression that patients
benefit from PK. This inconsistency seems worthy of further
investigation.
In this study, LCVA and CS, with and without glare, were
measured and compared across age similar groups of
keratoconus, PK, forme fruste keratoconus, and normal
subjects. This was done to determine whether LCVA detected
losses in keratoconus subjects that were independent of VA,
to add to the published data on contrast vision in PK subjects,
and to investigate the value of glare testing in keratoconus
and PK subjects. Vision was assessed using standard clinical
tests so that those which proved most useful could then be
used for routine clinical testing, or incorporated into a
protocol for PK for keratoconus outcomes research. The study
groups were selected to be uncomplicated, stable, and typical
of the condition and, in addition, a forme fruste keratoconus
group was included to investigate the potential confounding
effect of disease severity sampling on comparing keratoconus
subjects with PK and normal subjects.
SUBJECTS AND METHODS
Informed consent was obtained from all subjects after the
nature of the study had been fully explained. The tenets of
the Declaration of Helsinki were followed and the study
gained approval from the Flinders University ethics commit-
tee. Inclusion criteria were age 15 years or older, and normal
healthy eyes with a VA better than 0.1 logMAR (6/7.5 Snellen
equivalent) for the control group, or keratoconus (for the
keratoconus group), or having undergone PK for keratoconus
with an uncomplicated postoperative course (for example, no
Abbreviations: CS, contrast sensitivity; GLLVCA, low contrast visual
acuity glare loss; GLPRCS, Pelli-Robson contrast sensitivity glare loss; LCL,
low contrast loss; LCVA, low contrast visual acuity; PK, penetrating
keratoplasty; PRCS, Pelli-Robson contrast sensitivity; VA, visual acuity
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rejection, cataract development, etc) of at least 12 months
(for the PK group). Keratoconus was defined by the staging
system of Krumeich et al as being at least stage 1 (eccentric
corneal steepening, induced myopia/astigmatism ,5D, cor-
neal radii ,48D, Vogt’s striae, no scars).31 Subjects with
probable mild keratoconus as suggested by a history of
keratoconus or having had PK for keratoconus in the other
eye, as well as abnormal retinoscopy but not meeting the
criteria for stage 1, were included as a separate forme fruste
keratoconus group.
Exclusion criteria were any ocular pathology (other than
keratoconus for the keratoconus group) or abnormality such
as amblyopia and strabismus, any previous ocular surgery
(other than penetrating keratoplasty for the PK group), any
neurological problem, systemic disease, or taking of any
medication which may affect contrast sensitivity, inability to
speak English sufficiently to be instructed to perform the
tests, insufficient mental ability to perform the tests, and
physical disability which would make it arduous to perform
the tests (for example, wheelchair bound). Subjects with
keratoconus and PK for keratoconus were drawn from the
anterior segment clinic of the Department of Ophthalmology
at Flinders Medical Centre (FMC) on a consecutive atten-
dance basis. Control subjects were drawn from medical
students and staff of FMC.
Data were collected on the visual performance of 11 eyes of
11 keratoconus subjects, six eyes of six forme fruste
keratoconus subjects, 21 eyes of 21 PK subjects, and 24 eyes
of 24 normal subjects. The subjects had a mean age of 36.4
(SD 9.8) years. Data were collected in a single session. All
subjects were refracted and optimally corrected before data
collection. For the subjects who normally wore contact lenses
(keratoconus 8/11, PK 7/21, normal 2/24) refraction and
optimal correction took place over their contact lenses. The
measurements taken were logMAR high contrast visual
acuity, LCVA, Pelli-Robson contrast sensitivity (PRCS),
LCVA with glare, and PRCS with glare.
Both VA and LCVA were measured on a computerised
monitor based system.32 The program utilises the psychophy-
sical ‘‘staircase’’ method, using a forced choice protocol, to
determine the acuity end point, which is taken as the average
of 13 staircase reversals. This offers excellent reliability and
validity and is free from learning effects. The program uses
the same 564 letters used in Bailey-Lovie logMAR charts and
the results are given in logMAR.32 Low contrast visual acuity
is analogous to VA testing except that the target optotypes are
reduced in contrast. Twenty five per cent (Weber) contrast
optotypes were utilised since this has been reported to be the
most suitable contrast level for detecting visual loss in early
cataracts under glare conditions and thus may be suitable for
keratoconus subjects.33 Testing was conducted at 3.0 metres
and the monitor had a maximum luminance of 185 cd/m2.
Low contrast visual acuity was also measured under glare
conditions (LCVAglare).
There is no accepted standardised method for glare testing.
In this study, LCVA and Pelli-Robson contrast sensitivity
were measured with and without the presence of a light
source directed at the subject. The glare source consisted of
two projection lamps placed either side of the test chart and
monitor. The baseline room illuminance was 80 lux. The
luminance of the projector sources was 1800 cd/m2. Natural
pupils were used and care taken to ensure neither occlusion
of the glare source nor macular photostress occurred.34
The Pelli-Robson contrast sensitivity (PRCS) chart was
used according to previously published methodology.35 36 This
test was chosen from among other available clinical charts for
its superior validity and reliability36 37 especially compared to
sinusoidal grating charts such as the Vistech and FACT.38 The
use of a letter reading task for both CS and LCVA testing also
allowed easy comparison of the two techniques. The Pelli-
Robson chart was positioned 3 metres from the subject and
had a luminance of 100 cd/m2. The test was scored by the
modified method of letter by letter scoring,39 and results were
given in units of log contrast sensitivity (logCS). Contrast
sensitivity was also measured under the same glare condi-
tions (PRCSglare) as LCVAglare.
The results are reported as raw measures and three derived
measures of contrast and glare loss. Taking the simple
arithmetic difference between glare and no glare, or high and
low contrast demonstrates the effect of contrast or glare
independent of baseline VA or CS. This facilitates comparison
of groups of disease versus no disease where matching for VA
is not possible. Low contrast loss (LCL) is defined as the
difference between the high contrast VA and LCVA:
LCL = LCVA 2 VA.40 41 Low contrast visual acuity glare loss
(GLLVCA) is defined as the difference between the LCVAglare
and LCVA: GLLCVA = LCVAglare 2 LCVA.
40 Pelli-Robson
contrast sensitivity glare loss (GLPRCS) is defined as the
difference between PRCS and PRCSglare: GLPRCS = PRCS 2
PRCSglare.40
One way analyses of variance (ANOVA) with Sheffé post
hoc significance testing were used to compare groups. All
statistical analyses were performed on the SPSS software
package v10.0 (SPSS Inc, Chicago, IL, USA).
RESULTS
The results of visual performance of the normal control group
and the study groups are listed in table 1. The three groups
were similar for age (F2,53 = 3.32; p .0.05). The normal
controls performed better on all raw vision measures than
both the keratoconus and PK groups. Similarly, the PK group
performed better than the keratoconus group. However, as
the groups were not matched for VA (F2,48 = 30.60; p,0.001),
they were also compared using three difference measures.
Only two significantly different results were identified. The
keratoconus group had a greater low contrast loss than the
normal group (0.15 (0.12) v 0.05 (0.04), F2,48 = 6.16; p,0.01,
post hoc Sheffé p,0.05)—that is, the measurement of LCVA
identified loss of vision in the keratoconus group not
predicted by VA testing. Conversely, the keratoconus group
had a smaller glare loss with the Pelli-Robson contrast
sensitivity chart than the normal group (20.16 (0.36) v 0.07
(0.11), F2,49 = 4.23; p,0.05, post hoc Sheffé p,0.05)—that
is, the vision in the normal group worsened under glare but
improved in the keratoconus group. On all three difference
measures the PK group was indistinguishable from the
normal and keratoconus groups. Low contrast visual acuity
and CS testing did identify visual loss in keratoconus and PK
not appreciated with VA testing, but glare testing did not
provide any such useful information.
To examine the influence of disease severity on vision loss
in the keratoconus group, a forme fruste keratoconus group
was also tested. This group was age similar (33.0 (13.0) years;
p.0.05) and was also indistinguishable from normals on all
measures of vision (VA 20.15 (0.04) p.0.05; LCVA 20.06
(0.08) p.0.05; LCVAglare 20.03 (0.09) p.0.05; PRCS 1.65
(0.12) p.0.05; PRCSglare 1.65 (0.15) p.0.05; LCL 0.10
(0.05) p.0.05; GLLCVA 0.03 (0.09) p.0.05; GLPRCS 0.00 (0.13)
p.0.05).
DISCUSSION
The normal control group performed significantly better on
all raw measures of vision compared to the keratoconus and
PK groups. However, this chiefly reflects that the normal and
study groups were not matched for VA. When adjusting for
VA differences by using the difference measures low contrast
loss and glare loss, the normal group was only significantly
better on LCL (logMAR drop between VA and LCVA) and
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only compared to the keratoconus group (normal 0.05 (0.04),
keratoconus 0.15 (0.12); p,0.05). The PK group was
indistinguishable from both normal and keratoconus groups
on these three difference measures. This suggests that VA is a
very effective measure for distinguishing between normal,
keratoconus, and PK subjects, but that CS and LCVA do
provide some additional information.
Previous studies on keratoconus subjects have found
reduced LCVA compared to normal subjects, but none of
these studies controlled for VA by looking at LCL.9 14 19 23–25
However, deriving LCL from published VA and LCVA data
suggests there is slightly greater LCL in keratoconus subjects
compared to normals (at 10% but not 30% contrast),14 slightly
more LCL in keratoconus subjects with apical corneal scarring
compared to keratoconus subjects without scarring,23 24 and
greater LCL in more severe keratoconus.25 While these reports
support our findings, these differences were not tested
statistically. Similarly, previous studies where CS was
measured in keratoconus found reduced CS compared to
normals, in some cases these losses were shown to be
independent of VA.11–22 Two of these studies measured PRCS
in keratoconus.21 22 Rose et al found smaller losses of PRCS
than we did, which may have been because they reported
binocular measurements, or because their keratoconus group
were less impaired than ours, which is possible since they
gave no definition of keratoconus, and all subjects were able
to habitually wear their optimal correction.21 Conversely,
Brahma et al’s group had much worse PRCS and VA than
ours, but this was because their group were all presenting for
surgery and were therefore unable to achieve satisfactory
visual correction.22 This conclusion is supported by their VA
and PRCS data for the other eye, which were better than our
keratoconus data, although these data were a mix of 12
keratoconus and six PK eyes.22 Another possible reason for
differences between studies is a difference in the relative
proportions of those wearing RGP contact lenses, as these
have been shown to improve contrast sensitivity in kerato-
conus compared to spectacle wearers.13 42
Low contrast visual acuity data in PK subjects has
previously been shown to include subnormal values in one
series,19 and to be indistinguishable from keratoconus eyes in
another.28 Subnormal CS after PK for keratoconus has also
been shown previously.15–17 19 26 Two longitudinal studies of
keratoconus subjects before and after PK both found
improved CS after PK.22 27 Several cross sectional studies
comparing PK to keratoconus eyes support this find-
ing.16 17 26 29 43 Our data consolidate these findings, in that
subjects with fully healed PK have CS better than keratoco-
nus subjects, but not as good as normals, and LCVA losses
which do not exceed normals. Those studies where PK
subjects have been shown to have greater deficits in CS than
keratoconus subjects were either in the early postoperative
period,27 28 or during a rejection episode.29
The two glare loss measures did not yield any further vision
losses in the keratoconus and PK groups, not identified with
LCVA or PRCS testing alone. For GLLCVA, all groups were
similar, but for GLPRCS, the normal group (0.07 (0.11)) was
significantly worse than the keratoconus group (20.16
(0.36); F2,49 = 4.23; p,0.05, post hoc Sheffé p,0.05). While
the keratoconus group did better than the normal group in
terms of the change in CS under glare conditions the raw
PRCS under glare scores were still worse in the keratoconus
group compared to the normals (1.41 (0.21) v 1.73 (0.11);
F2,49 = 17.09; p,0.001, post hoc Sheffé p,0.001). That glare
testing is of no value in either keratoconus or PK reflects that
the main mechanism of visual loss in keratoconus and PK is
optical aberration rather than light scatter.19 Our same
experimental set-up finds large glare losses in cataract since
the main mechanism of optical disturbance from cataract is
forward light scatter.40 If the main problem is aberrations,
visual performance must be pupil dependent.44 Therefore, the
use of natural pupils, which will constrict in the presence of a
bright glare source, reduces the chance of finding decreased
visual performance under glare and, in this study, probably
explains the significant increase in PRCS in the presence of
glare for the keratoconus group. This raises the possibility
that glare testing with a less bright glare source may be more
useful in keratoconus. Alternatively, instead of testing vision
under glare, perhaps low illumination testing, such as with
the Smith Kettlewell Institute Low Luminance (SKILL)
Card,45 which could allow use of maximum natural pupil
size and hence sample more aberrated optics, may be more
appropriate in keratoconus.
The only longitudinal study of keratoconus subjects before
and after PK (n = 18), in which glare testing was done (using
the Brightness Acuity Tester (BAT) with VA and PRCS
Table 1 Mean (SD) for the five raw vision measures* and three difference measures in normals, keratoconus, and
penetrating keratoplasty subjects
Normal (n = 24) Keratoconus (n = 11) PK (n = 21) Statistics
Age 33.7 (8.6) 35.0 (11.1) 41.2 (7.9)










20.11 (0.08) 0.35 (0.28) 0.08 (0.14) (F2,48 = 31.87; p,0.001 post hoc
normal,keratoconus, normal,PK,
p,0.001, PK,keratoconus, p,0.01)
Pelli-Robson contrast sensitivity 1.80 (0.13) 1.10 (0.28) 1.39 (0.22) (F2,51 = 50.69; p,0.001 post hoc
normal.keratoconus, normal.PK,
p,0.001, PK.keratoconus, p,0.01)
Pelli-Robson contrast sensitivity under glare 1.73 (0.11) 1.25 (0.46) 1.41 (0.21) (F2,49 = 17.09; p,0.001 post hoc
normal.keratoconus, p,0.001,
normal .PK, p,0.01)
Low contrast loss 0.05 (0.04) 0.15 (0.12) 0.12 (0.09) (F2,48 = 6.16; p,0.01 post hoc
normal,keratoconus, p,0.05)
Glare loss (low contrast visual acuity) 0.02 (0.08) 0.06 (0.11) 20.02 (0.08) (F2,49 = 4.23; p,0.05 post hoc
keratoconus.normal, p,0.05)Glare loss (Pelli-Robson contrast sensitivity) 0.07 (0.11) 20.16 (0.36) 20.01 (0.21)
*Visual acuity (VA), low contrast visual acuity (LCVA), low contrast visual acuity under glare (LCVAglare) (all in logMAR), Pelli-Robson contrast sensitivity (PRCS),
Pelli-Robson contrast sensitivity measured under glare (PRCSglare) (both in logCS).
Low contrast loss = LCVA 2 VA, low contrast glare loss = LCVAglare 2 LCVA, PRCS glare loss = PRCS 2 PRCSglare.
Vision in keratoconus 655
www.bjophthalmol.com
charts), found glare losses for keratoconus but not for PK.22
The reason for the difference to our results may be that the
BAT glare source is not as bright as our projector glare source,
thus may cause less pupillary constriction. Two small cross
sectional studies (n = 6 and 7) also showed a trend toward
CS deficit under glare for keratoconus subjects compared
with normal subjects.16 17 Conversely, two small studies
(n = 4 and 5) found glare losses in PK greater than those
seen in keratoconus.15 16 These small studies may have
included keratoconus cases with apical corneal scarring,
which has been shown to cause forward light scatter and
measurable glare loss.24 30 Similarly, the PK series may have
included cases with graft oedema, perhaps early in the
postoperative recovery, which could also cause glare loss.
Therefore, while glare testing is not useful for measuring
vision in all cases of keratoconus or PK, it may still be useful
in the presence of apical corneal scarring, or graft oedema—
for example, in the first month after surgery27 or after a
rejection episode.29
Defining the point along a spectrum from normal to
disease state at which the transition from one entity to the
other occurs is not a difficulty confined to keratoconus.46
However, for keratoconus this difficulty has led to debate
over the existence of unilateral keratoconus,47 issues for study
design,48 and difficulty determining patient suitability for
laser refractive surgery.49 For this study we defined kerato-
conus according to an accepted, but conservative system.31 To
illustrate that the inclusion of more mild cases of keratoco-
nus could confound the results, we also tested a group of six
forme fruste keratoconus subjects. This group were indis-
tinguishable from the normal group on all vision measures. If
we had included these subjects in the keratoconus group
then the results of this study would have been different.
This highlights the problem of sampling disease severity
for cross sectional design studies. This problem could be
avoided by using a longitudinal outcome study design.
Indeed, the clinical impression that PK patients see better
than keratoconus patients arises from comparing pre-PK
keratoconus patients who want visual improvement to their
post-PK state. Such pre-PK keratoconus subjects often
proceed to surgery because they are unable to tolerate
optimum refractive correction, so it is possible that this
clinical impression is exaggerated by undercorrection of
refractive error. Thus it is important in longitudinal study
execution to ensure vision testing is conducted with optimal
refraction in place.
While PK provides vision superior to keratoconus, it does
not achieve levels of vision as good as normals. The pursuit of
improvement in the surgical management of keratoconus
requires vision testing to establish these improvements.
Based on our findings, studies of treatments for keratoconus
should include a measure of contrast vision, either PRCS or
LCVA.
ACKNOWLEDGEMENTS
KP is supported by NHMRC Sir Neil Hamilton Fairley Fellowship
0061.
Authors’ affiliations
. . . . . . . . . . . . . . . . . . . . .
K Pesudovs, P Schoneveld, R J Seto, D J Coster, Department of
Ophthalmology, Flinders Medical Centre and Flinders University,
Bedford Park, South Australia, 5042, Australia
REFERENCES
1 Nottingham J. Practical observations on conical cornea: and on the short
sight, and other defects of vision connected with it. London: John Churchill:
Liverpool: Deighton & Laughton, 1854:1–19.
2 Krachmer JH, Feder RS, Belin MW. Keratoconus and related non-
inflammatory corneal thinning disorders. Surv Ophthalmol
1984;28:293–322.
3 Lawless M, Coster DJ, Phillips AJ, et al. Keratoconus: diagnosis and
management. Aust NZ J Ophthalmol 1989;17:33–60.
4 Feder RS. Noninflammatory ectatic disorders. In: Krachmer JH, Mannis MJ,
Holland EJ, eds. Cornea: cornea and external disease: clinical diagnosis and
management. St Louis: Mosby, 1997;2:1091–106.
5 Maguire LJ. Ectatic corneal degenerations. In: Kaufman HE, Barron BA,
McDonald MB, eds. The cornea, 2nd ed. Oxford: Butterworth-Heinemann,
1998:525–50.
6 Rabinowitz Y. Keratoconus. Surv Ophthalmol 1998;42:297–319.
7 Lass JH, Lembach RG, Park SB, et al. Clinical management of keratoconus: a
multi-center analysis. Ophthalmology 1990;97:433–45.
8 Crews MJ, Driebe WT, Stern GA. The clinical management of keratoconus: a
6 year retrospective study. CLAO J 1994;20:194–7.
9 Gordon MO, Schechtman KB, Davis LJ, et al. Visual acuity repeatability in
keratoconus: impact on sample size. Collaborative Longitudinal Evaluation of
Keratoconus (CLEK) Study Group. Optom Vis Sci 1998;75:249–57.
10 McLeod SD. Beyond snellen acuity: the assessment of visual function after
refractive surgery. Arch Ophthalmol 2001;119:1371–3.
11 Hess RF, Carney LG. Vision through an abnormal cornea: a pilot study of the
relationship between visual loss from corneal distortion, corneal edema,
keratoconus and some allied corneal pathology. Invest Ophthalmol Vis Sci
1979;18:476–83.
12 Carney LG. Visual loss in keratoconus. Arch Ophthalmol
1982;100:1282–5.
13 Carney LG. Contact lens correction of visual loss in keratoconus. Acta
Ophthalmol 1982;60:795–802.
14 Zadnik K, Mannis MJ, Johnson CA, et al. Rapid contrast sensitivity assessment
in keratoconus. Am J Optom Physiol Opt 1987;64:693–7.
15 Carney LG, Jacobs RJ. Problems remaining after keratoplasty for keratoconus.
Clin Exp Optom 1989;72:22–5.
16 Carney LG, Lembach RG. Management of keratoconus: comparative visual
assessments. CLAO J 1991;17:52–8.
17 Carney LG, Kelly CG. Visual losses after myopic epikeratoplasty. Arch
Ophthalmol 1991;109:499–502.
18 Rabin J, Wicks J. Measuring resolution in the contrast domain: the small letter
contrast test. Optom Vis Sci 1996;73:398–403.
19 Applegate RA, Hilmantel G, Howland HC, et al. Corneal first surface optical
aberrations and visual performance. J Refract Surg 2000;16:507–14.
20 Maeda N, Sato S, Watanabe H, et al. Prediction of letter contrast
sensitivity using videokeratographic indices. Am J Ophthalmol
2000;129:759–63.
21 Rose K, Harper R, Tromans C, et al. Quality of life in myopia. Br J Ophthalmol
2000;84:1031–4.
22 Brahma A, Ennis F, Harper R, et al. Visual function after penetrating
keratoplasty for keratoconus: a prospective longitudinal evaluation.
Br J Ophthalmol 2000;84:60–6.
23 Barr JT, Yackels T. Corneal scarring in keratoconus-measurements and
influence on visual acuity. Int Contact Lens Clin 1991;22:173–5.
24 Zadnik K, Barr JT, Edrington TB, et al. Corneal scarring and vision in
keratoconus: a baseline report from the Collaborative Longitudinal Evaluation
of Keratoconus (CLEK) Study. Cornea 2000;19:804–12.
25 Betts AM, Mitchell GL, Zadnik K. Visual performance and comfort with the
Rose K lens for keratoconus. Optom Vis Sci 2002;79:493–501.
26 Mannis MJ, Zadnik K, Johnson CA, et al. Contrast sensitivity after penetrating
keratoplasty. Arch Ophthalmol 1987;105:1220–3.
27 Khong AM, Mannis MJ, Plotnik RD, et al. Computerised topographic analysis
of the healing graft after penetrating keratoplasty for keratoconus.
Am J Ophthalmol 1993;115:209–15.
28 Mannis MJ, Zadnik K, Johnson CA. The effect of penetrating keratoplasty on
contrast sensitivity in keratoconus. Arch Ophthalmol 1984;102:1513–6.
29 Zadnik KM, MJ Johnson, CA. An analysis of contrast sensitivity in identical
twins with keratoconus. Cornea 1984;3:99–103.
30 Miller D, Sanghvi S. Contrast sensitivity and glare testing in corneal disease.
In: Nadler MP, Miller D, Nadler DJ, eds. Glare and contrast sensitivity for
clinicians. New York: Springer Verlag, 1990:45–52.
31 Krumeich JH, Daniel J, Knulle A. Live-epikeratophakia for keratoconus.
J Cataract Refract Surg 1998;24:456–63.
32 Lenne RC, Smith G, Vingrys AJ. Automated visual acuity testing. Clin Exp
Optom 1994;77:190–5.
33 Regan D, Giaschi DE, Fresco BB. Measurement of glare sensitivity in cataract
patients using low-contrast letter charts. Ophthal Physiol Opt
1993;13:115–23.
34 Laidlaw DAH, Haddad R. Can second eye cataract surgery be justified? Eye
1993;7:680–6.
35 Pelli DG, Robson JG, Wilkins AJ. The design of a new letter chart for
measuring contrast sensitivity. Clin Vis Sci 1988;2:187–99.
36 Elliott DB, Sanderson K, Conkey A. The reliability of the Pelli-Robson contrast
sensitivity chart. Ophthal Physiol Opt 1990;10:21–4.
37 Elliott DB, Bullimore MA. Assessing the reliability, discriminative ability,
and validity of disability glare tests. Invest Ophthalmol Vis Sci
1993;34:108–19.
38 Pesudovs K, Hazel CA, Doran RML, et al. The usefulness of Vistech and FACT
contrast sensitivity charts for cataract and refractive surgery outcomes
research. Br J Ophthalmol 2004;88:11–16.
39 Elliott DB, Bullimore MA, Bailey IL. Improving the reliability of the Pelli-Robson
contrast sensitivity test. Clin Vis Sci 1991;6:471–5.
40 Pesudovs K, Coster DJ. Assessment of visual function in cataract patients with
a mean visual acuity of 6/9. Aust NZ J Ophthalmol 1996;24:S5–9.
41 Bullimore MA, Olson MD, Maloney RK. Visual performance after
photorefractive keratectomy with a 6-mm ablation zone. Am J Ophthalmol
1999;128:1–7.
656 Pesudovs, Schoneveld, Seto, et al
www.bjophthalmol.com
42 Wicker D, Sanislo S, Green DG. Effect of contact lens correction of sine wave
contrast sensitivity in keratoconus patients after penetrating keratoplasty.
Optom Vis Sci 1992;69:342–6.
43 Mannis MJ, Zadnik K, Johnson C, et al. Contrast sensitivity after
epikeratoplasty. Cornea 1988;7:280–4.
44 Calver RI, Cox MJ, Elliott DB. Effect of aging on the monochromatic
aberrations of the human eye. J Opt Soc Am A 1999;16:2069–78.
45 Haegerstrom-Portnoy G, Brabyn J, Schneck ME, et al. The SKILL Card: an
acuity test of reduced luminance and contrast. Invest Ophthalmol Vis Sci
1997;38:207–18.
46 Foster PJ, Buhrmann R, Quigley HA, et al. The definition and
classification of glaucoma in prevalence surveys. Br J Ophthalmol
2002;86:238–42.
47 Holland DR, Maeda N, Hannush SB, et al. Unilateral keratoconus.
Incidence and quantitative topographic analysis. Ophthalmology
1997;104:1409–13.
48 Bawazeer AM, Hodge WG, Lorimer B. Atopy and keratoconus: a multivariate
analysis. Br J Ophthalmol 2000;84:834–6.
49 Colin J, Velou S. Current surgical options for keratoconus. J Cataract Refract
Surg 2003;29:379–86.
Vision in keratoconus 657
www.bjophthalmol.com
